Cerebral arteriovenous malformation embolisation is a therapeutic, neuroradiological procedure involving injection of bucrylate glue into the nidus of the A V malformation to obliterate the abnormal vascular network. These procedures may involve significant risks, are often long and thereby necessitate the need for some form of sedation and for adequate monitoring of the cerebral, cardiovascular and respiratory systems. The anaesthetic management of a series of twenty patients undergoing embolisation of a cerebral arteriovenous malformation is outlined, seven general and nineteen neurolept anaesthetics being administered. Neurolept anaesthesia is the preferred technique as neurological assessment during the procedure is possible and complications may be diagnosed immediately. Systemic arterial hypotension may facilitate the embolisation process and various agents, including glyceryl trinitrate and sodium nitroprusside, have been employed for this purpose.
facilities, and is undertaken in a department of diagnostic radiology. Patients are selected for this technique after group discussion regarding the possible benefits and risks of the procedure and Human Rights Committee approval has been given. The Department considers the technique of bucrylate embolisation of CA VMs to be experimental and consequently requires informed consent from all patients undergoing this procedure. Informed consent presupposes an explanation of the nature of the procedure, the materials involved, the anaesthetic management, the risks of the procedure, the possible requirement for subsequent surgery and the freedom to withdraw consent without detriment to management at any stage.
The latex catheters are directed, via the femoral artery, to one or more feeder arteries of the CA VM and isobutyl-2-cyanoacrylate (bucrylate) is injected into the nidus of the CA VM. The bucrylate solidifies very quickly Anaesthesia and Intensive Care, Vol. 16 inside the CA VM, occluding part or all of the abnormal vascular network 2 . 3 (Figure 2 ). This process may be facilitated by systemic arterial hypotension which directly reduces blood flow through the CA VM and so reduces the transit time of bucrylate through the CA VM. This allows bucrylate to occlude many vessels of the CA VM and hopefully not pass into the venous drainage system or into normal cortical tissue which may occur if transit time is too rapid. Occlusion of the venous part of the CA VM without completely occluding arterial feeders may result in the CA VM becoming swollen and bleeding. This is more likely to occur in high flow CA VMs with multiple large feeders. Temporary profound hypotension in these situations is likely to reduce this complication of venous embolisation. The obliteration of the nidus of the CA VM should be the goal of successful embolisation,4 or with larger CA VMs reduction in their vascularity by occlusion of major feeder vessels, so reducing the risks associated with surgical intervention. This is often done as a two-stage procedure over several days, depending of the number of feeder vessels to be emboli sed. It may take up to seven hours during which time the patient must lie still on an X-ray table, in a darkened room with X-ray tubes and plates surrounding the head and anaesthetic monitoring devices in place.
METHODS
The anaesthetic records of twenty patients undergoing embolisation of CA VM at the Royal Perth Hospital between the years 1985 and 1987 were reviewed. All of these procedures had been carried out by one of us (B. O'M).
RESULTS
Twenty patients presented to the anaesthetic department for a total of 26 procedures during this three-year period. The age range of the patients at presentation was 12-66 years with eleven males and nine females undergoing embolisation. Seven general and 19 neurolept anaesthetics were administered.
Anaesthetic management
Patients undergoing embolisation of a CA VM can be given either a general anaesthetic with neuromuscular blockade or neurolept anaesthesia. The advantage of the former is easier control of blood pressure, respiration and complete elimination of patient movement. The advantages of a neurolept anaesthetic are that the patient can be neurologically assessed at any stage of the procedure and changes in neurological condition may give early warnings of adverse intracerebral events. Frequently, several major feeder vessels are embolised and sequential neurological examinations have been carried out prior to proceeding to further embolisation under the same anaesthetic.
Preoperatve assessment
A complete history of previous cerebrovascular disease and symptoms must be obtained including any history of epilepsy and anticonvulsant treatment. An assessment of the patient's intracranial pressure is made as some of these patients may have already had an intracerebral bleed. A history of transient ischaemic attacks or cerebrovascular occlusion would militate against vigorous hypotension during embolisation. Any history of ischaemic heart disease would also be of importance. Current smoking, chronic lung disease producing secretions or back pain would make it difficult for the patient to lie still without coughing or moving for a prolonged time and should favour a general anaesthetic.
If a neurolept anaesthetic technique is chosen at the preoperative visit, the patient should be made fully aware of the conditions in the radiology department. The patient should be given considerable reassurance that the anaesthetist will be on hand close by should the patient find any part of the procedure intolerable. This aspect of the preoperative visit is very important for a successful neurolept anaesthetic technique and cannot be overemphasised. A baseline preoperative coagulation profile including activated clotting time (ACT) is also obtained as systemic heparinization is employed during the procedure.
Intraoperalive management
Oral premedication is usually with diazepam and maxalon. This is combined with two oral doses of nifedipine, one given two hours before the procedure and the other the night before at the request of the radiologists. For anticipated long procedures a sheepskin underblanket and un nary catheter are used. Intravenous access is secured and monitoring of heart rate with an ECG, peripheral haemoglobin saturation with a pulse oximeter and blood pressure via an intra-arterial cannula are considered mandatory. Pulse oximetry is considered essential because of the reduced lighting conditions during the procedure. Respiration is monitored clinically by the anaesthetist in the neurolept group with end tidal CO 2 levels monitored in patients who receive a general anaesthetic. The cerebral function monitor is now used routinely, with particular application during the use of temporary profound hypotension.
N euroleptanaesthesia is induced with combinations of fentanyl, droperidol, promethazine and midazolam, until the patient is sedated and drowsy but rousable. Incremental doses of these drugs are given throughout the procedure to ensure an immobile patient. The patient should be responsive enough to undergo coarse neurological testing during the procedure if necessary. Supplementary oxygen is administered if significant hypotension is employed or if the patient's preoperative condition or pulse oximetry deem it necessary.
General anaesthesia consists of a balanced anaesthetic technique utilizing long-acting neuromuscular blockade, intermittent positive pressure ventilation, nitrous oxide, intravenous narcotic agents and volatile agents if intracranial pressure is normal. These patients are ventilated to normocarbia to eliminate the effects of carbon dioxide fluctuations on cerebral vascular tone. A heat and moisture exchanger is incorporated in the ventilator circuit as the radiology suite is maintained at cool temperatures and heat losses may be considerable.
Maintaining normotension in the neurolept group has proved difficult and we have employed varying hypotensive agents to maintain a depressed stable blood pressure. The choice of technique and ideal arterial pressure for controlled hypotension remains controversial. Drugs used include incremental bolus doses of metoprolol or propranolol, beta blockers having little direct action on the Anaesthesia and Intensive Care, Vol. 16, No. 3, August, 1988 cerebral circulation, alpha blocking agents such as phentolamine, and infusions of glyceryl trinitrate or sodium nitroprusside. When moderate hypotension is required, we have found glyceryl trinitrate to provide rapid, stable and reversible hypotension with the apparent absence of metabolic sideeffects. When very low arterial pressures are required for short periods, sodium nitroprusside has been used. Of the drugs currently used for hypotension, sodium nitroprusside probably maintains cerebral perfusion the best. 22 These agents have proved useful in controlling the hypertensive response secondary to vascular spasm often associated with rapid retrieval of the intracerebral arterial catheters immediately following bucrylate injection.
Fluid balance is carefully monitored as a osmotic diuresis can occur from high doses of contrast medium used during long procedures.
Systemic heparinization is achieved intravenously usually :;;;2 mg/kg and at the end of the procedure is reversed with protamine sulphate until normal clotting is demonstrated and an activated clotting time (ACT) approaches preoperative levels. Heparinization carries some risk when manipulation of catheters is occurring in the vicinity of abnormal cerebral vascular tissue.
Complications
Many complications of the procedure are possible but the more common include embedding the balloon and catheter in the bucrylate cast, bucrylate emboli passing to vessels other than those feeding the CA VM or even the lungs and occasionally venous outflow occlusion without arterial inflow obstruction,4 which may lead to delayed bleeding of the CA VM as in the following case.
CASE REPORT 1
A 25-year-old woman presented with an extensive arteriovenous malformation in the left parieto-occipital region with a greatly enlarged venous drainage system. It was concluded that embolisation of the middle cerebral feeding vessels would achieve a substantial reduction of the CA VM bed prior to surgical excision.
Anaesthesia and Intensive Care. Vol. 16. No. 3, August, 1988 Due to the extensive nature of the malformation and its large venous drainage, a significant degree of hypotension at the time of embolisation was deemed essential to the success of the procedure. The blood pressure was 110170 mmHg prior to induction of general anaesthesia. Immediately before the first embolisation, a sodium nitroprusside infusion was commenced to lower the blood pressure to 80/40 mmHg (MAP 53 mmHg). There was no change in cerebral electrical activity as seen on the cerebral function monitor. After successful embolisation, the infusion was .ceased and the blood pressure returned to 100/60 mmHg. Re-institution of nitroprusside infusion prior to the second embolisation transiently reduced the pressure to 65/30 mmHg (MAP 42 mmHg), again with no detectable change in cerebral electrical activity.
Anaesthesia was uneventful but after twenty-four hours she developed signs consistent with marked oedema of the CA VM, confirmed on CT scan. This was probably caused by post-embolisation venous thrombosis distal to the site of embolisation or a tissue reaction. Her neurological signs improved rapidly with recommencement of a dexamethazone regime and she was discharged to await surgical excision of the CAVM.
CASE REPORT 2
Acute subarachnoid haemorrhage from catheter manipulation around abnormal vascular tissue of the CA VM may occur as in the following case.
A 15-year-old boy presented following subarachnoid haemorrhage associated with a right parietal CA VM. A two-stage procedure under neurolept anaesthesia was planned with the first embolisation under a neurolept anaesthetic being uneventful. Controlled hypotension was achieved with a combination of metoprolol and glyceryl trinitrate.
Two days later neurolept anaesthesia was induced for the second stage until the patient was sedated but rousable with controlled hypotension achieved using glyceryl trinitrate. He was systemically heparinized. Two hours after the commencement of the procedure, during catheterisation of the right anterior cerebral artery he became unrousable, and both pupils became dilated. The procedure was abandoned and he was immediately intubated and hyperventilated.
The presumptive diagnosis of subarachnoid haemorrhage was confirmed by CT scan, he remained unconscious and later died.
Neuropathology confirmed acute subarachnoid haemorrhage with evidence of a ruptured aberrant artery supplying the CA VM. The presumed cause of rupture was manipulation of the intra-luminal catheter with a weakened vessel wall.
Tissue reactions to bucrylate are thought to be rare in abnormal vessels but more severe in normal arteries. 8 ,9 Although a tissue reaction to bucrylate may occur, neurological complications are generally due to reflux of bucrylate into normal cortical vessels. 4 The long-term effects ofbucrylate in the tissues are unknown.
Another possible effect on local cerebral vasculature is a reduced sump effect with better flow to normal vessels near the CA VM after embolisation. Such an increased flow may cause vasogenic oedema of normal vessel distributions surrounding the CA VM after embolisation. 4 
DISCUSSION
The natural history of CA VMs suggests that embolisation instead of surgery will be increasingly attempted in the future. Longterm follow-up suggests a 10% mortality attributable to the CA VM and 24% of patients disabled by the lesion. 5 In the same series of patients parietal, central and infratentorial lesions were associated with a higher mortality than frontal, temporal and occipital CA VMs. Other workers have related symptoms of epilepsy and bleeding from CA VM to the likelihood of further bleeding and the time course for subsequent bleeds. 6 Size of CAVM has also been a major prognostic factor; 92% of small CA VMs will bleed.?
Nifedipine (1,4-dihydropyridine) has been shown to reverse both in vitro and in vivo cerebral vasospasm. It has been one of the most widely studied calcium antagonists in this respect. I? The beneficial effects of nifedipine on ischaemic heart disease are well known and the drug is very safe in these patients. '8 ,'9 The possible interactions of calcium channel blockers with general anaesthetic agents have also recently been reviewed and nifedipine remains a safe adjuvant to both general and neurolept anaesthesia. 20 At present, calcium antagonists seem promising for treatment of patients with regional cerebral ischaemia from vasospasm such as in subarachnoid haemorrhage but more studies are required to confirm original reports. 2I Although this procedure may invoke considerable discomfort and is invasive, general anaesthesia is not mandatory. The ability to diagnose neurological complications immediately and to be able to perform regular neurological examinations during the procedure has influenced us to choose neurolept anaesthesia in the majority of cases. There is always the small but attendant risk of any general anaesthetic to consider.
Factors favouring the choice of general anaesthesia in these patients are patient request, age (infants or young children), uncooperative patients, potential airway problems (chronic cough, smoking, snoring), back pain, anticipated long procedure where complete immobility can be assured and suspected raised ICP where sedation is contraindicated. General anaesthesia can ensure control ofICP and easier regulation of blood pressure where its control is likely to be problematical.
The use of deliberate profound arterial hypotension during some procedures under general anaesthesia has necessitated cerebral function monitoring. It has been demonstrated that preservation of voltage of cerebral electrical activity on the cerebral function monitor trace without evidence of slowing is not associated with a postoperative neurological deficit in patients undergoing plastic surgical procedures. '2 These criteria have been described as indicative of preserved cerebral perfusion in other patients. ' 3 Ideally on-line frequency analysis of the EEG recorded from the arterial boundary zones would provide the most reliable indication of cerebral ischaemia but this equipment was not available in the department. '4 Patients receiving a neuroleptanaesthetic also receive cerebral function monitoring even though conscious level can be monitored during periods of deliberate profound arterial hypotension.
Anaesthesia and Intensi,'e Care, Vol, 16, No, 3, August, 1988 With the increased use of embolisation for both intra-and extracerebral A VMs, more patients will be presented for anaesthetic management during these procedures.
